COMMUNIQUÉS West-GlobeNewswire

BioRestorative Therapies Appoints Jason M. Lipetz, M.D. to its Scientific Advisory Board
25/07/2018
MELVILLE, N.Y., July 25, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced that Jason M [...]
TGOD Spin Off Provides Cannabis Investors with Ground Floor Opportunity -- CFN Media
25/07/2018
SEATTLE, July 25, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Lexington Biosciences Receives HeartSentry USPTO Patent Approval
25/07/2018
--Patent encompasses functional claims, underlying science and methods VANCOUVER, British Columbia, July 25, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a [...]
Food & Tobacco Veteran Takes the Reins at Tree of Knowledge -- CFN Media
25/07/2018
SEATTLE, July 25, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
MEDIFIRST SOLUTIONS ANNOUNCES COMPANY UPDATE
25/07/2018
Freehold, NJ , July 25, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology and specialty pharmacy drug and management consulting [...]
RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data:
25/07/2018
Effects of Chronic Systemic Low-impact Ampakine Treatment on Neurotrophin Expression in Rat Brain Glen Rock, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “ [...]
Anavex Life Sciences Presents New Data Identifying Treatment Response Biomarkers in Alzheimer’s Disease Patients Treated with Investigational ANAVEX®2-73 at 2018 Alzheimer’s Association International Conference (AAIC)
25/07/2018
An Analysis of More Than 33,000 Genes Identified Variants That May Enable a Precision Medicine Approach to Alzheimer’s Disease Research and Treatment The Study Identified 80 Percent of Participants as ANAVEX®2-73 [...]
PolarityTE, Inc. Provides Commercial Update
25/07/2018
SALT LAKE CITY, July 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company, today announced an update on the Company’s commercial progress. [...]
CV Sciences, Inc. Pre-Announces Record Second Quarter 2018 Sales
25/07/2018
Company Expects to Report Sales of $12.3 Million, up 203% from the same quarter in 2017 Will Host Earnings Call on Wednesday, August 1, 2018 LAS VEGAS, July 25, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) ( [...]
Teladoc to Participate in Upcoming Investor Conference
25/07/2018
PURCHASE, NY, July 25, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE:TDOC), the global leader in virtual care, announced today that Mark Hirschhorn, chief operating officer and chief financial officer, will participate [...]
Scythian Chief Medical Officer Professor Michael Barnes Expands Global Influence as a Cannabis Key Opinion Leader
25/07/2018
TORONTO, July 25, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) today announced [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
25/07/2018
FIT Biotech Oy Company release July 25, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Grandevo® CG and Regalia® CG Approved by the California Department of Pesticide Regulation
25/07/2018
Innovative Tools for a New Era: Grandevo® CG and Regalia® CG Are Effective Tools for Controlling Economically Damaging Mites, Insect Pests and Plant Diseases and Boosting Yields and Quality for Cannabis DAVIS, Calif., [...]
OpGen Announces Date of Second Quarter 2018 Financial Results Conference Call
25/07/2018
GAITHERSBERG, Md., July 25, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that the Company will report financial results for the three and six months ended June 30, 2018 after close of the U.S. [...]
Imagin Medical Announces Stock Options Granted
25/07/2018
VANCOUVER, B.C. and BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) (the “Company”) announced today that, pursuant to the Company’s Stock Option [...]
OrthoPediatrics Corp. to Report Second Quarter 2018 Financial Results on August 8, 2018
25/07/2018
Conference Call to Discuss Results on August 9, 2018 at 8:00 a.m. ET WARSAW, Ind., July 25, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on [...]
Albireo Appoints Patrick Horn MD, PhD as Chief Medical Officer
25/07/2018
--- Pediatrician with extensive orphan drug development expertise --- --- Experience with multiple Phase 3 programs and FDA submissions --- BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a [...]
Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics
25/07/2018
CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced that it [...]
Nabriva Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
25/07/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa. and SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of [...]

Pages